Kantify

TLDR

Kantify offers Sapian, an AI-driven small molecule discovery platform designed to identify drug candidates for undruggable targets by screening billions of compounds without requiring known 3D structures or modulators.

Overview

Sapian is Kantify's universal AI engine that overcomes traditional structure-based drug discovery limitations by leveraging hundreds of millions of datapoints to find IP-clean chemistry for challenging therapeutic targets. The platform has been validated across multiple target categories including ion channels, antigens, and ubiquitin-like proteins, and can screen 13 billion compounds in under a day.